Gentamicin sulfate CAS NO:1405-41-0
Wide Range of Antibacterial Properties
Multiple Clinical Treatment Scenarios
Potent Synergistic Effect in Combined Medication
Stable Chemical Property and Reliable Curative Effect
This pharmaceutical compound mainly targets both systemic and regional infectious diseases triggered by Gram-negative pathogenic bacteria, including Escherichia coli, Shigella dysenteriae, Klebsiella pneumoniae, Proteus spp. and Pseudomonas aeruginosa. Within ophthalmic treatment, it is widely prescribed to address ocular ailments such as conjunctivitis and keratitis.
Parameters
Melting point | 218-237°C |
alpha | D25 +102° |
density | 1.000 g/cm3 |
storage temp. | 2-8°C |
solubility | H2O: 50 mg/mL As stock solution, store at −20°C. Stable at 37°C for 5 days. |
form | |
color | colorless to light yellow |
Odor | odorless |
PH | 4.0-5.5 (0.1g/mL in H2O) |
optical activity | [α]20/D +110±8°, c = 1% in H2O |
biological source | Micromonospora purpurea |
Water Solubility | Soluble in water |
Merck | 134403 |
InChIKey | RDEIXVOBVLKYNT-HDZPSJEVSA-N |
CAS DataBase Reference | 1405-41-0(CAS DataBase Reference) |
EPA Substance Registry System | Gentamicin sulfate (1405-41-0) |
Safety Information | |
Hazard Codes | Xn |
Risk Statements | 42/43 |
Safety Statements | 23-36/37-45-22-24/25 |
WGK Germany | 2 |
RTECS | LY2625000 |
F | 3 |
HS Code | 29419010 |
Toxicity | LD50 in mice (mg base/kg): 430 i.p.; 485 s.c.; 75 i.v.; >9050 orally (Black) |
Oral administration of this antibacterial agent is available for intestinal infectious disorders and preoperative intestinal disinfection prior to colorectal operations. Moreover, pairing it with metronidazole or clindamycin can effectively cut down the risk of infectious complications after colon surgery.






